Research led by Komen grantee Aleix Prat has shown that HER2+ - TopicsExpress



          

Research led by Komen grantee Aleix Prat has shown that HER2+ breast cancer can be classified into 4 different subtypes. These new classifications of different tumor subtypes will ultimately facilitate more effective treatment tailored to a specific tumor, as well as advance targeted therapy against HER2+ breast cancer. Read the study: bit.ly/1hzowQD Learn about tumor characteristics: sgk.mn/19ALlDo
Posted on: Sat, 18 Jan 2014 17:00:02 +0000

Trending Topics



Recently Viewed Topics




© 2015